Daniel Schneider

Dr. Daniel Schneider


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2026 in Clinical Spine Surgery
Verified
Journal Article
Closed access
EBEthan D. L. Brown D.L. Brown
Ethan D. L. Brown D.L. Brown
Barnabas Obeng-GyasiBarnabas Obeng-Gyasi
Barnabas Obeng-Gyasi
BSBrett Silber
Brett Silber
DSDaniel Schneider
Daniel Schneider
WTWeston Troja
Weston Troja
GMGordon Mao
Gordon Mao
Study Design: This cross-sectional study was conducted on version 7 of the All of Us Researcher Workbench database and involved a cohort of patients with intervertebral disc disorders, spondylolysis, lumbago, and unspecified lumbar disc disorders who completed the Health Care Access and Utilization Survey. Participants with ethno-racial identities of non-Hispanic White, non-Hispanic Black, and Hispanic were included for regression analyses. Objective: Determine whether self-reported barriers to care predict lumbar spinal surgery utilization among patients of various backgrounds with degenerative lumbar spine conditions (DLSC). Summary of Background Data: Access to surgery is often influenced by demographic and socioeconomic factors, with ethnic minorities facing greater healthcare barriers. Little is known regarding the effect of self-reported obstacles on surgical utilization. Methods: This cross-sectional survey utilized the All of Us Research Program database to analyze adults diagnosed with DLSC who completed the Health Care Access and Utilization survey. Subgroup analyses were conducted for White, Black, and Hispanic participants. Results: Of 23,258 patients, 1245 (5.4%) underwent lumbar spine surgery. Surgical utilizers tended to be older (mean age: 68 vs. 64 y, P <0.001) and more likely male (44% vs. 33%, P <0.001). Unadjusted regression models indicated that barriers were associated with reduced surgical utilization overall (UOR: 0.74, 95% CI: 0.65–0.84, P <0.001) and among White participants (UOR: 0.78, 95% CI: 0.68–0.89, P <0.001). Specific barriers, including nervousness (UOR: 0.70, 95% CI: 0.56–0.86), cost concerns, and differing provider background (UOR: 0.71, 95% CI: 0.58–0.88, P =0.001), were significantly associated with reduced surgical utilization. Subgroup analyses highlighted important racial/ethnic differences: excessive deductibles (AOR: 0.22, 95% CI: 0.05–0.91, P =0.037) and out-of-pocket costs (AOR: 0.28, 95% CI: 0.10–0.77, P =0.014) were linked to lower surgical utilization among Hispanic participants. Conclusions: Self-reported barriers to care, particularly cost-related concerns and nervousness, may be associated with variable surgical utilization in DLSC patients across racial/ethnic groups.

20 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
AEAhmed N. Elguindy
Ahmed N. Elguindy
ECEric R. Cochran
Eric R. Cochran
KDKhaled Dibs
Khaled Dibs
KFKatelyn Fernando
Katelyn Fernando
MAMark Addington
Mark Addington
DBDukagjin M. Blakaj
Dukagjin M. Blakaj
Background/Objectives: Stereotactic body radiation therapy (SBRT) provides improved pain response and local control for spinal metastases. However, management of local failure after initial SBRT is challenging. We report institutional outcomes, dosimetry, and toxicity for reSBRT following SBRT. Methods: We retrospectively reviewed 61 lesions (55 patients) treated with reSBRT after prior SBRT. Both SBRT courses delivered a median dose of 27 Gy. Patients underwent clinical and radiological evaluation every three months. Toxicity was graded using CTCAE v5.0. Dosimetric parameters for the spinal cord (SC), cauda equina (CE), planning organ-at-risk volumes (PRV), and thecal sac were converted to equivalent dose in 2 Gy fractions (EQD2) using the linear–quadratic model (α/β = 2). Results: Median follow-up was 10.3 months. Forty lesions (65%) were cervicothoracic and 21 (35%) were lumbosacral. One- and two-year overall survival (OS) were 45% and 29%, respectively, and one- and two-year local control (LC) were 89% and 88%, respectively. Gastrointestinal primary tumors were associated with inferior LC (HR 2.41, 95% CI 1.11–5.23, p = 0.026). Fifteen patients (27%) reported myelitis/neuropathic symptoms during follow-up; four (7%) developed new post-radiation myelitis or neuropathy (RMN) without radiologic progression. Five patients (9%) developed vertebral compression fractures (VCF). Cumulative EQD2 was not significantly associated with RMN (p = 0.344); all affected patients had thecal sac EQD2 > 95.5 Gy and relevant nerve roots EQD2 > 108 Gy. Conclusions: ReSBRT provided a favorable LC with acceptable toxicity. High cumulative dose to the thecal sac and nerve roots may contribute to neurologic toxicity as peripheral nerve injury.